2024 annual financial data
Aldeyra Therapeutics 2024 Operating margin
Aldeyra Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -60,117,032 USD and net income was -55,851,444 USD.
Operating cash flow was -43,208,747 USD.
Get free Aldeyra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -60,117,032 USD
- Net income
- -55,851,444 USD
- Operating cash flow
- -43,208,747 USD